» Articles » PMID: 22865900

Moderate Ovarian Stimulation Does Not Increase the Incidence of Human Embryo Chromosomal Abnormalities in in Vitro Fertilization Cycles

Overview
Specialty Endocrinology
Date 2012 Aug 7
PMID 22865900
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Context: A high chromosomal abnormalities rate has been observed in human embryos derived from in vitro fertilization (IVF) treatments. The real incidence in natural cycles has been poorly studied, so whether this frequency may be induced by external factors, such as use of gonadotropins for ovarian stimulation, remains unknown.

Design: We conducted a prospective cohort study in a University-affiliated private infertility clinic with a comparison between unstimulated and stimulated ovarian cycles in the same women. Preimplantation genetic screening by fluorescence in situ hybridization was performed in all viable d 3 embryos.

Objective: The primary objective was to compare the incidence of embryo chromosomal abnormalities in an unstimulated cycle and in an ulterior moderate ovarian stimulated cycle. Secondary outcome measures were embryo quality, blastocyst rate of biopsied embryos, number of normal blastocysts per donor, type of chromosomal abnormalities, and clinical outcome.

Results: One hundred eighty-five oocyte donors were initially recruited for the unstimulated cycle, and preimplantation genetic screening could be performed in 51 of them, showing 35.3% of embryo chromosomal abnormalities. Forty-six of them later completed a stimulated cycle. The sperm donor sample was the same for both cycles. The proportion of embryos displaying abnormalities in the unstimulated cycle was 34.8% (16 of 46), whereas it was 40.6% (123 of 303) in the stimulated cycle with risk difference=5.8 [95% confidence interval (CI)=-20.6-9.0], and relative risk=1.17 (95% CI=0.77-1.77) (P=0.45). When an intrasubject comparison was made, the abnormalities rate was 34.8% (95% CI=20.5-49.1) in the unstimulated cycle and 38.2% (95% CI=30.5-45.8) in the stimulated cycle [risk difference=3.4 (95% CI=-17.9-11.2); P=0.64]. No differences were observed for embryo quality and type of chromosomal abnormalities.

Conclusions: Moderate ovarian stimulation in young normo-ovulatory women does not significantly increase the embryo aneuploidies rate in in vitro fertilization-derived human embryos as compared with an unstimulated cycle. Whether these results can be extrapolated to infertile patients is still unknown.

Citing Articles

Effects of ovarian stimulation on embryo euploidy: an analysis of 12 874 oocytes and 3106 blastocysts in cycles with preimplantation genetic testing for monogenic disorders.

Ma C, Long X, Yan L, Zhu X, Chen L, Li R Hum Reprod Open. 2024; 2024(4):hoae054.

PMID: 39399299 PMC: 11470209. DOI: 10.1093/hropen/hoae054.


Total gonadotropin dose did not affect euploid blastocyst rates: an analysis of more than 19,000 oocytes.

Shuai J, Liu W, Wan S, Chen Q, Zhang Q, Zhou D J Assist Reprod Genet. 2024; 41(9):2385-2396.

PMID: 39001951 PMC: 11405638. DOI: 10.1007/s10815-024-03183-w.


In Vitro Culture of Mammalian Embryos: Is There Room for Improvement?.

Gualtieri R, De Gregorio V, Candela A, Travaglione A, Genovese V, Barbato V Cells. 2024; 13(12.

PMID: 38920627 PMC: 11202082. DOI: 10.3390/cells13120996.


Ovarian Stimulation with FSH Alone versus FSH plus a GnRH Antagonist for Elective Freezing in an Oocyte Donor/Recipient Programme: A Protocol for a Pilot Multicenter Observational Study.

Messinis I, Messini C, Papanikolaou E, Makrakis E, Loutradis D, Christoforidis N J Clin Med. 2023; 12(7).

PMID: 37048828 PMC: 10095010. DOI: 10.3390/jcm12072743.


Metaphase-II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case-control study in women of advanced maternal age.

Vaiarelli A, Cimadomo D, Scarafia C, Innocenti F, Amendola M, Fabozzi G J Assist Reprod Genet. 2022; 40(1):169-177.

PMID: 36586005 PMC: 9840736. DOI: 10.1007/s10815-022-02684-w.


References
1.
Munne S, Magli C, Adler A, Wright G, de Boer K, Mortimer D . Treatment-related chromosome abnormalities in human embryos. Hum Reprod. 1997; 12(4):780-4. DOI: 10.1093/humrep/12.4.780. View

2.
Conway D, Patel S, Liem J, Fan K, Jalian R, Williams 3rd J . The risk of cytogenetic abnormalities in the late first trimester of pregnancies conceived through assisted reproduction. Fertil Steril. 2010; 95(2):503-6. DOI: 10.1016/j.fertnstert.2010.09.019. View

3.
Verpoest W, Fauser B, Papanikolaou E, Staessen C, Van Landuyt L, Donoso P . Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF. Hum Reprod. 2008; 23(10):2369-71. DOI: 10.1093/humrep/den269. View

4.
Rodrigo L, Peinado V, Mateu E, Remohi J, Pellicer A, Simon C . Impact of different patterns of sperm chromosomal abnormalities on the chromosomal constitution of preimplantation embryos. Fertil Steril. 2009; 94(4):1380-1386. DOI: 10.1016/j.fertnstert.2009.05.061. View

5.
Plachot M, Veiga A, Montagut J, de Grouchy J, Calderon G, Lepretre S . Are clinical and biological IVF parameters correlated with chromosomal disorders in early life: a multicentric study. Hum Reprod. 1988; 3(5):627-35. DOI: 10.1093/oxfordjournals.humrep.a136758. View